Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; Division of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Cell Mol Gastroenterol Hepatol. 2021;12(3):1073-1092. doi: 10.1016/j.jcmgh.2021.05.003. Epub 2021 May 8.
BACKGROUND & AIMS: Epithelial cells form a monolayer at mucosal surface that functions as a highly selective barrier. Lysophosphatidic acid (LPA) is a bioactive lipid that elicits a broad range of biological effects via cognate G protein-coupled receptors. LPA receptor 5 (LPA) is highly expressed in intestinal epithelial cells, but its role in the intestine is not well-known. Here we determined the role of LPA in regulation of intestinal epithelial barrier.
Epithelial barrier integrity was determined in mice with intestinal epithelial cell (IEC)-specific LPA deletion, Lpar5. LPA was orally administered to mice, and intestinal permeability was measured. Dextran sulfate sodium (DSS) was used to induce colitis. Human colonic epithelial cell lines were used to determine the LPA-mediated signaling pathways that regulate epithelial barrier.
We observed increased epithelial permeability in Lpar5 mice with reduced claudin-4 expression. Oral administration of LPA decreased intestinal permeability in wild-type mice, but the effect was greatly mitigated in Lpar5 mice. Serum lipopolysaccharide level and bacterial loads in the intestine and liver were elevated in Lpar5 mice. Lpar5 mice developed more severe colitis induced with DSS. LPA transcriptionally regulated claudin-4, and this regulation was dependent on transactivation of the epidermal growth factor receptor, which induced localization of Rac1 at the cell membrane. LPA induced the translocation of Stat3 to the cell membrane and promoted the interaction between Rac1 and Stat3. Inhibition of Stat3 ablated LPA-mediated regulation of claudin-4.
This study identifies LPA as a regulator of the intestinal barrier. LPA promotes claudin-4 expression in IECs through activation of Rac1 and Stat3.
上皮细胞在黏膜表面形成单层,作为高度选择性的屏障发挥功能。溶血磷脂酸(LPA)是一种生物活性脂质,通过同源 G 蛋白偶联受体引发广泛的生物学效应。LPA 受体 5(LPA)在肠道上皮细胞中高度表达,但它在肠道中的作用尚不清楚。在此,我们旨在确定 LPA 在调节肠道上皮屏障中的作用。
利用肠道上皮细胞(IEC)特异性 LPA 缺失小鼠(Lpar5)来确定 LPA 在肠道上皮屏障中的作用。用 LPA 对小鼠进行口服给药,并测量肠道通透性。使用葡聚糖硫酸钠(DSS)诱导结肠炎。利用人结肠上皮细胞系来确定调节上皮屏障的 LPA 介导的信号通路。
我们观察到 Lpar5 小鼠中 Claudin-4 表达减少,导致上皮通透性增加。LPA 对野生型小鼠的肠道通透性有降低作用,但在 Lpar5 小鼠中作用大大减弱。Lpar5 小鼠的血清脂多糖水平和肠道及肝脏中的细菌负荷增加。Lpar5 小鼠在 DSS 诱导下发生更严重的结肠炎。LPA 转录调控 Claudin-4,这种调控依赖于表皮生长因子受体的转位激活,这诱导 Rac1 定位于细胞膜。LPA 诱导 Stat3 向细胞膜易位,并促进 Rac1 和 Stat3 之间的相互作用。Stat3 的抑制消除了 LPA 对 Claudin-4 的调节作用。
本研究确定了 LPA 是肠道屏障的调节因子。LPA 通过激活 Rac1 和 Stat3 促进 IEC 中 Claudin-4 的表达。